Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


RESMED INC   FYE=6 (June)

Annual - Income Statement - Company Specific

Fiscal period2022202120202019201820172016201520142013
Period End Date6/30/20226/30/20216/30/20206/30/20196/30/20186/30/20176/30/20166/30/20156/30/20146/30/2013
Revenues----------2,066.741,838.711,678.911,554.971,514.46
Revenue-Sleep and Respiratory Care products3,177.302,823.242,602.382,330.782,183.19----------
Revenue-Software as a Service400.83373.59354.63275.79157.00----------
Total Revenues3,578.133,196.832,957.012,606.572,340.202,066.741,838.711,678.911,554.971,514.46
Cost of sales----------864.99772.22667.52565.19573.80
Voluntary product recall expenses--------------------
Cost of sales-Sleep and Respiratory Care products1,365.421,177.311,067.97977.22929.35----------
Cost of sales-Software as a Service148.75135.29121.6692.7648.68----------
Amortization of acquired intangible assets-Sleep and Respiratory Care products4.114.908.588.597.22----------
Amortization of acquired intangible assets-Software as a Service35.5540.2341.0233.9220.05----------
Gross Profit2,024.311,839.101,717.791,494.071,334.901,201.751,066.501,011.40989.79940.66
Amortization of acquired intangible assets31.0831.0830.0932.4219.1246.5823.928.679.7310.14
Research and development253.58225.28201.95180.65155.15144.47118.65114.87118.23120.12
Education, research and settlement charge------------------24.77
In-process research and development charge (note 20)--------------------
Selling, general and administrative739.37670.39676.69645.01600.37553.97488.06478.63450.41430.80
Restructuring expenses--8.67--9.4018.4312.366.91--6.33--
Donations to Research Foundations--------------------
Acquisition expenses------(6.12)--(10.08)--------
Litigation settlement expenses----0.60(41.20)--(8.50)--------
Total Operating Expenses1,024.03935.42908.13914.81793.07775.95637.55602.16584.70585.83
Operating Income (Loss)1,000.29903.68809.66579.26541.83425.80428.95409.24405.09354.82
Interest expense22.3123.6339.3636.1628.3628.2411.215.786.136.39
Loss attributable to equity method investments(8.49)(11.21)(25.06)(15.83)------------
Gain (loss) on equity investments (note 5)(12.20)14.52(14.52)--------------
Interest income (expense), net------2.3016.3817.0916.8626.2131.2438.87
Other, net3.200.302.36(10.73)(8.54)4.104.966.250.88(2.19)
Gain (loss) on extinguishment of debt--------------------
Government grants--------------------
Other: License fees--------------------
Other: Gain/(loss) on foreign currency hedging position--------------------
Other: Gain/(loss) on foreign currency transactions--------------------
Other: Other--------------------
Other: Realized gain on sale of marketable securities--------------------
Other: Impairment of cost method investment--------------------
Other: Gain on sale of real property--------------------
Other: Gain on sale of plant and equipment--------------------
Other: Gain on sale of business assets and contracts--------------------
Total other income (expenses), net--------------------
Pre-Tax Income - U.S(85.92)71.8760.55(34.47)42.63(4.99)1.7911.43----
Non-U.S1,046.40811.80672.54553.32478.69423.73437.78424.49----
Income before Income taxes960.48883.66733.09518.85521.31418.74439.57435.92431.08385.12
Current: Federal4.38(115.11)9.7928.66128.9716.4724.3328.4318.9342,065.00
Current: State10.709.046.907.600.95(1.16)5.810.701.33888.00
Deferred: Federal(12.61)(22.79)(13.00)(30.46)9.4911.395.64(4.27)(0.42)(1,345.00)
Deferred: State(2.77)(4.21)(3.34)(5.41)(0.35)2.71(1.64)(0.18)(0.08)(264.00)
Current- Non-U.S177.79531.81124.60127.5468.8665.6158.0250.8955.6853,713.00
Deferred- Non-U.S3.5710.41(13.54)(13.67)(2.19)(18.55)(4.99)7.4610.37(17,071.00)
Income taxes181.05409.16111.41114.26205.7276.4687.1683.0385.8177.99
Net Income (Loss) Available to Common Shareholders779.44474.51621.67404.59315.59342.28352.41352.89345.27307.13
Continuing Operations- (Basic)--------------------
Basic Earnings Per Share5.343.274.312.832.212.422.512.512.442.15
Continuing Operations- (Diluted)--------------------
Diluted Earnings Per Share5.303.244.272.802.192.402.492.472.392.10
Weighted Average Shares Outstanding (Basic)146.07145.31144.34143.11142.76141.36140.24140.47141.47142.95
Weighted Average Shares Outstanding (Diluted)147.04146.45145.65144.48143.99142.45141.67142.69144.36146.41